FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1502916649> ?p ?o ?g. }

• W1502916649 endingPage "240" @default.
• W1502916649 startingPage "228" @default.
• W1502916649 abstract "Purpose: To perform a meta-analysis of randomized controlled trials (RCTs) that compared the effects of treatment with intravitreal injections of triamcinolone acetonide (TA) with the standard of care for ocular inflammatory diseases. Methods: Medline database was searched for causes of macular edema terms in association with intravitreal triamcinolone. The primary outcome of interest included changes in best corrected visual acuity (BCVA) and central macular thickness (CMT). Pooled summary estimates for primary outcomes were calculated as weighted mean differences (WMD) either on a fixed- or random-effect model. Results: A total of 8 studies were included for quantitative analysis. Treatment with intravitreal TA showed improvement in BCVA compared with standard of care at 1 month (WMD, −0.09; 95% confidence interval [CI], −0.17 to −0.02), at 4 months (WMD, −0.09; 95% CI, −0.15 to −0.03), at 6 months (WMD, −0.13; 95% CI, −0.21 to −0.05), and in CMT at 1 month (WMD, −88.14; 95% CI, −105.86 to −70.43). Increased intraocular pressure (IOP) among patients treated with intravitreal TA was found at 4 months (WMD, 2.83; 95% CI, 1.96 to 3.70), persisting also at 12 months (WMD, 3.78; 95% CI, 2.97 to 4.59), compared with those receiving the standard of care. All outcomes are mostly equivalent at further follow-up times. Conclusions: Intravitreal injections of TA may offer certain advantages over the standard of care for ocular inflammatory diseases, especially in the early stage of follow-up. However, it is necessary to take into account risks and benefits of TA treatment for ocular inflammatory diseases due to possible ocular hypertension elicited, in general, by intravitreal injection of corticosteroids." @default.
• W1502916649 created "2016-06-24" @default.
• W1502916649 creator A5003827674 @default.
• W1502916649 creator A5051911488 @default.
• W1502916649 creator A5066054299 @default.
• W1502916649 creator A5078620103 @default.
• W1502916649 date "2015-05-01" @default.
• W1502916649 modified "2023-09-23" @default.
• W1502916649 title "Intravitreal Triamcinolone Acetonide in the Treatment of Ophthalmic Inflammatory Diseases with Macular Edema: A Meta-Analysis Study" @default.
• W1502916649 cites W1485105115 @default.
• W1502916649 cites W1565832645 @default.
• W1502916649 cites W160117109 @default.
• W1502916649 cites W1898187276 @default.
• W1502916649 cites W1965161689 @default.
• W1502916649 cites W1966080291 @default.
• W1502916649 cites W1979025521 @default.
• W1502916649 cites W1984158303 @default.
• W1502916649 cites W1986215651 @default.
• W1502916649 cites W1986408411 @default.
• W1502916649 cites W1994272890 @default.
• W1502916649 cites W1994515616 @default.
• W1502916649 cites W2000552582 @default.
• W1502916649 cites W2003640321 @default.
• W1502916649 cites W2007337013 @default.
• W1502916649 cites W2018410534 @default.
• W1502916649 cites W2019604331 @default.
• W1502916649 cites W2022886290 @default.
• W1502916649 cites W2023277376 @default.
• W1502916649 cites W2025420377 @default.
• W1502916649 cites W2029569083 @default.
• W1502916649 cites W2036729487 @default.
• W1502916649 cites W2046328116 @default.
• W1502916649 cites W2047058258 @default.
• W1502916649 cites W2055741676 @default.
• W1502916649 cites W2057880134 @default.
• W1502916649 cites W2066300747 @default.
• W1502916649 cites W2072964734 @default.
• W1502916649 cites W2074283027 @default.
• W1502916649 cites W2075706854 @default.
• W1502916649 cites W2093269333 @default.
• W1502916649 cites W2094310573 @default.
• W1502916649 cites W2101039050 @default.
• W1502916649 cites W2111693183 @default.
• W1502916649 cites W2128533866 @default.
• W1502916649 cites W2141540280 @default.
• W1502916649 cites W2148230234 @default.
• W1502916649 cites W2166108068 @default.
• W1502916649 cites W2168858270 @default.
• W1502916649 cites W2241627328 @default.
• W1502916649 cites W2805868637 @default.
• W1502916649 cites W4229823998 @default.
• W1502916649 cites W4243582587 @default.
• W1502916649 cites W4256306353 @default.
• W1502916649 cites W4322701112 @default.
• W1502916649 doi "https://doi.org/10.1089/jop.2014.0094" @default.
• W1502916649 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25825799" @default.
• W1502916649 hasPublicationYear "2015" @default.
• W1502916649 type Work @default.
• W1502916649 sameAs 1502916649 @default.
• W1502916649 citedByCount "7" @default.
• W1502916649 countsByYear W15029166492016 @default.
• W1502916649 countsByYear W15029166492017 @default.
• W1502916649 countsByYear W15029166492019 @default.
• W1502916649 countsByYear W15029166492021 @default.
• W1502916649 crossrefType "journal-article" @default.
• W1502916649 hasAuthorship W1502916649A5003827674 @default.
• W1502916649 hasAuthorship W1502916649A5051911488 @default.
• W1502916649 hasAuthorship W1502916649A5066054299 @default.
• W1502916649 hasAuthorship W1502916649A5078620103 @default.
• W1502916649 hasConcept C118487528 @default.
• W1502916649 hasConcept C126322002 @default.
• W1502916649 hasConcept C141071460 @default.
• W1502916649 hasConcept C168563851 @default.
• W1502916649 hasConcept C2776251621 @default.
• W1502916649 hasConcept C2778257484 @default.
• W1502916649 hasConcept C2778903070 @default.
• W1502916649 hasConcept C2780347916 @default.
• W1502916649 hasConcept C2781092963 @default.
• W1502916649 hasConcept C44249647 @default.
• W1502916649 hasConcept C71924100 @default.
• W1502916649 hasConcept C95190672 @default.
• W1502916649 hasConceptScore W1502916649C118487528 @default.
• W1502916649 hasConceptScore W1502916649C126322002 @default.
• W1502916649 hasConceptScore W1502916649C141071460 @default.
• W1502916649 hasConceptScore W1502916649C168563851 @default.
• W1502916649 hasConceptScore W1502916649C2776251621 @default.
• W1502916649 hasConceptScore W1502916649C2778257484 @default.
• W1502916649 hasConceptScore W1502916649C2778903070 @default.
• W1502916649 hasConceptScore W1502916649C2780347916 @default.
• W1502916649 hasConceptScore W1502916649C2781092963 @default.
• W1502916649 hasConceptScore W1502916649C44249647 @default.
• W1502916649 hasConceptScore W1502916649C71924100 @default.
• W1502916649 hasConceptScore W1502916649C95190672 @default.
• W1502916649 hasIssue "4" @default.
• W1502916649 hasLocation W15029166491 @default.
• W1502916649 hasLocation W15029166492 @default.
• W1502916649 hasOpenAccess W1502916649 @default.
• W1502916649 hasPrimaryLocation W15029166491 @default.

• next